BioNTech falls as it ends mid-stage trial of mRNA colorectal cancer vaccine

BioNTech's stock price declined as it halted the mid-stage clinical trial of its mRNA colorectal cancer vaccine.

AI CATALYST SCORE40 / 100Score computed by Sentinel V12

REFERENCE PRICENot measuredReference entry price at analysis time

Diagnosed At	Ticker	AI Score	Tier
2026-10-25 07:47:13	BNTX	50	Mid	View Report →
2026-10-13 15:32:23	BNTX	45	Mid	View Report →
2026-09-28 16:03:13	BNTX	45	Mid	View Report →

BNTX Analysis History (Last 30 Days)